Bioter Past Earnings Performance

Past criteria checks 0/6

Bioter's earnings have been declining at an average annual rate of -12.3%, while the Construction industry saw earnings growing at 49.5% annually. Revenues have been growing at an average rate of 15.3% per year.

Key information

-12.3%

Earnings growth rate

-12.3%

EPS growth rate

Construction Industry Growth41.8%
Revenue growth rate15.3%
Return on equityn/a
Net Margin-4,339.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

Robust Earnings May Not Tell The Whole Story For Bioter (ATH:BIOT)

May 06
Robust Earnings May Not Tell The Whole Story For Bioter (ATH:BIOT)

Recent updates

Robust Earnings May Not Tell The Whole Story For Bioter (ATH:BIOT)

May 06
Robust Earnings May Not Tell The Whole Story For Bioter (ATH:BIOT)

Revenue & Expenses Breakdown

How Bioter makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ATSE:BIOT Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-1210
31 Mar 240-1220
31 Dec 230-1220
30 Sep 230-1130
30 Jun 230-930
31 Mar 230-1020
31 Dec 220-1010
30 Sep 220-1010
30 Jun 220-1010
31 Mar 220-1010
31 Dec 210-910
30 Sep 210010
30 Jun 210810
31 Mar 210710
31 Dec 200610
30 Sep 200-210
30 Jun 200-1110
31 Mar 200-1010
31 Dec 190-910
30 Sep 190-1110
30 Jun 190-1310
31 Mar 190-1310
31 Dec 180-1310
30 Sep 180-1510
30 Jun 180-1810
31 Mar 180-1810
31 Dec 170-1810
30 Sep 170-1810
30 Jun 171-1810
31 Mar 171-1810
31 Dec 161-1810
30 Sep 160-1610
30 Jun 160-1010
31 Mar 160-1010
31 Dec 151-1010
30 Sep 153-1420
30 Jun 154-1420
31 Mar 155-1220
31 Dec 145-1420
30 Sep 144-1120
30 Jun 143-1330
31 Mar 143-1530
31 Dec 135-1430

Quality Earnings: BIOT is currently unprofitable.

Growing Profit Margin: BIOT is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BIOT is unprofitable, and losses have increased over the past 5 years at a rate of 12.3% per year.

Accelerating Growth: Unable to compare BIOT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BIOT is unprofitable, making it difficult to compare its past year earnings growth to the Construction industry (-0.07%).


Return on Equity

High ROE: BIOT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 14:40
End of Day Share Price 2024/12/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bioter S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution